References
Araki, Yasuto, Yoshimi Aizaki, Kojiro Sato, Hiromi Oda, Riki Kurokawa,
and Toshihide Mimura. 2018. “Altered Gene Expression Profiles of
Histone Lysine Methyltransferases and Demethylases in Rheumatoid
Arthritis Synovial Fibroblasts.” Clinical and Experimental
Rheumatology 36 (2): 314–16.
Bagislar, Sevgi, Arianna Sabò, Theresia R. Kress, Mirko Doni, Paola
Nicoli, Stefano Campaner, and Bruno Amati. 2016. “Smyd2 Is a
Myc-Regulated Gene Critical for MLL-AF9 Induced Leukemogenesis.”Oncotarget 7 (41): 66398–415.
https://doi.org/10.18632/oncotarget.12012.
Boehm, Daniela, Mark Jeng, Gregory Camus, Andrea Gramatica, Roland
Schwarzer, Jeffrey R. Johnson, Philip A. Hull, et al. 2017.
“SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency.”Cell Host and Microbe 21 (5): 569-579.e6.
https://doi.org/10.1016/j.chom.2017.04.011.
Bottino, Cinzia, Alessia Peserico, Cristiano Simone, and Giuseppina
Caretti. 2020. “SMYD3: An Oncogenic Driver Targeting Epigenetic
Regulation and Signaling Pathways.” Cancers 12 (1): 142.
https://doi.org/10.3390/cancers12010142.
Brown, Mark A., Melissa A. Edwards, Ilham Alshiraihi, Huimin Geng,
Joseph D. Dekker, and Haley O. Tucker. 2020. “The Lysine
Methyltransferase SMYD2 Is Required for Normal Lymphocyte Development
and Survival of Hematopoietic Leukemias.” Genes and Immunity 21
(2): 119–30. https://doi.org/10.1038/s41435-020-0094-8.
Brown, Mark A., Robert J. Sims, Paul D. Gottlieb, and Philip W. Tucker.
2006. “Identification and Characterization of Smyd2: A Split SET/MYND
Domain-Containing Histone H3 Lysine 36-Specific Methyltransferase That
Interacts with the Sin3 Histone Deacetylase Complex.” Molecular
Cancer 5 (1): 26. https://doi.org/10.1186/1476-4598-5-26.
Du, Shao Jun, Xungang Tan, and Jianshe Zhang. 2014. “SMYD Proteins: Key
Regulators in Skeletal and Cardiac Muscle Development and Function.”Anatomical Record 297 (9): 1650–62.
https://doi.org/10.1002/ar.22972.
Hay, Jodie, Kathryn Gilroy, Camille Huser, Anna Kilbey, Alma Mcdonald,
Amanda MacCallum, Ailsa Holroyd, Ewan Cameron, and James C. Neil. 2019.
“Collaboration of MYC and RUNX2 in Lymphoma Simulates T-Cell Receptor
Signaling and Attenuates P53 Pathway Activity.” Journal of
Cellular Biochemistry 120 (10): 18332–45.
https://doi.org/10.1002/jcb.29143.
Hwang, Inkyu, and Paul D. Gottlieb. 1995. “Bop: A New T-Cell-Restricted
Gene Located Upstream of and Opposite to Mouse CD8b.”Immunogenetics 42 (5): 353–61.
https://doi.org/10.1007/BF00179396.
———. 1997. “The Bop Gene Adjacent to the Mouse CD8b Gene Encodes
Distinct Zinc-Finger Proteins Expressed in CTLs and in Muscle.”Journal of Immunology (Baltimore, Md. : 1950) 158 (3):
1165–11674.
Li, Quanxi, Catherine R. Lawrence, Romana A. Nowak, Jodi A. Flaws, Milan
K. Bagchi, and Indrani C. Bagchi. 2018. “Bisphenol A and Phthalates
Modulate Peritoneal Macrophage Function in Female Mice Involving
SYMD2-H3K36 Dimethylation.” Endocrinology 159 (5): 2216–28.
https://doi.org/10.1210/en.2017-03000.
Lin, Fujia, Danjuan Wu, Dan Fang, Yao Chen, Haitao Zhou, and Caiwen Ou.
2019. “STAT3-Induced SMYD3 Transcription Enhances Chronic Lymphocytic
Leukemia Cell Growth in Vitro and in Vivo.” Inflammation
Research 68 (9): 739–49. https://doi.org/10.1007/s00011-019-01257-5.
Lin, Yi Ching, Yu Chih Lin, Ming Yii Huang, Po Lin Kuo, Cheng Chin Wu,
Min Sheng Lee, Chong Chao Hsieh, et al. 2017. “Tumor Necrosis
Factor-Alpha Inhibitors Suppress CCL2 Chemokine in Monocytes via
Epigenetic Modification.” Molecular Immunology 83: 82–91.
https://doi.org/10.1016/j.molimm.2017.01.009.
Liu, Cheng, Dawei Xu, Hongya Han, Yidong Fan, Frida Schain, Zhonghua Xu,
Hans Erik Claesson, Magnus Björkholm, and Jan Sjöberg. 2012.
“Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3
Lysine 4 Methylation/Demethylation.” PLoS ONE 7 (12): 1–9.
https://doi.org/10.1371/journal.pone.0052703.
Ma, Wei, Yingying Zhang, Yu Qi, and Shidong Guo. 2019. “STAT3 Promotes
Chronic Lymphocytic Leukemia Progression through Upregulating SMYD3
Expression.” Archives of Medical Science 15 (5): 1163–75.
https://doi.org/10.5114/aoms.2018.77733.
Mossel, Dieuwertje M., Kondaiah Moganti, Vladimir Riabov, Christel
Weiss, Stefan Kopf, Julio Cordero, Gergana Dobreva, et al. 2020.
“Epigenetic Regulation of S100A9 and S100A12 Expression in
Monocyte-Macrophage System in Hyperglycemic Conditions.”Frontiers in Immunology 11 (June): 1–19.
https://doi.org/10.3389/fimmu.2020.01071.
Nagata, D. E.De Almeida, H. A. Ting, K. A. Cavassani, M. A. Schaller, S.
Mukherjee, C. Ptaschinski, S. L. Kunkel, and N. W. Lukacs. 2015.
“Epigenetic Control of Foxp3 by SMYD3 H3K4 Histone Methyltransferase
Controls ITreg Development and Regulates Pathogenic T-Cell Responses
during Pulmonary Viral Infection.” Mucosal Immunology 8 (5):
1131–43. https://doi.org/10.1038/mi.2015.4.
Oliveira-Santos, Wilson, Doralina Amaral Rabello, Antônio Roberto
Lucena-Araujo, Fábio Morato de Oliveira, Eduardo Magalhaes Rego, Fábio
Pittella Silva, and Felipe Saldanha-Araujo. 2016. “Residual Expression
of SMYD2 and SMYD3 Is Associated with the Acquisition of Complex
Karyotype in Chronic Lymphocytic Leukemia.” Tumor Biology 37
(7): 9473–81. https://doi.org/10.1007/s13277-016-4846-z.
Parmar, Naveen, Pragya Chandrakar, and Susanta Kar. 2020. “Leishmania
Donovani Subverts Host Immune Response by Epigenetic Reprogramming of
Macrophage M(Lipopolysaccharides + IFN-γ)/M(IL-10) Polarization.”The Journal of Immunology 204 (10): 2762–78.
https://doi.org/10.4049/jimmunol.1900251.
Peveling-Oberhag, Jan, Franziska Wolters, Claudia Döring, Dirk Walter,
Ludger Sellmann, René Scholtysik, Marco Lucioni, et al. 2015. “Whole
Exome Sequencing of Microdissected Splenic Marginal Zone Lymphoma: A
Study to Discover Novel Tumor-Specific Mutations.” BMC Cancer 15
(1): 1–10. https://doi.org/10.1186/s12885-015-1766-z.
Rasmussen, Tara, and Haley Tucker. 2018. “Loss of SMYD1 Results in
Perinatal Lethality via Selective Defects within Myotonic Muscle
Descendants.” Diseases 7 (1): 1.
https://doi.org/10.3390/diseases7010001.
Sakamoto, Luis Henrique Toshihiro, Rosangela Vieira de Andrade, Maria
Sueli Soares Felipe, Andrea Barretto Motoyama, and Fabio Pittella Silva.
2014. “SMYD2 Is Highly Expressed in Pediatric Acute Lymphoblastic
Leukemia and Constitutes a Bad Prognostic Factor.” Leukemia
Research 38 (4): 496–502.
https://doi.org/10.1016/j.leukres.2014.01.013.
Spellmon, Nicholas, Joshua Holcomb, Laura Trescott, Nualpun Sirinupong,
Zhe Yang, Nicholas Spellmon, Joshua Holcomb, Laura Trescott, Nualpun
Sirinupong, and Zhe Yang. 2015. “Structure and Function of SET and MYND
Domain-Containing Proteins.” International Journal of Molecular
Sciences 16 (1): 1406–28. https://doi.org/10.3390/ijms16011406.
Stender, Joshua D, Gabriel Pascual, Wen Liu, Minna U Kaikkonen, Kevin
Do, Nathanael J Spann, Michael Boutros, Norbert Perrimon, Michael G
Rosenfeld, and Christopher K Glass. 2012. “Control of Proinflammatory
Gene Programs by Regulated Trimethylation and Demethylation of Histone
H4K20.” Molecular Cell 48 (1): 28–38.
https://doi.org/10.1016/j.molcel.2012.07.020.
Velinder, Matthew, Jason Singer, Diana Bareyan, Jessica Meznarich,
Christopher M. Tracy, James M. Fulcher, David McClellan, et al. 2016.
“GFI1 Functions in Transcriptional Control and Cell Fate Determination
Require SNAG Domain Methylation to Recruit LSD1.” Biochemical
Journal 473 (19): 3355–69. https://doi.org/10.1042/BCJ20160558.
Vougiouklakis, Theodore, Riyue Bao, Yusuke Nakamura, and Vassiliki
Saloura. 2017. “Protein Methyltransferases and Demethylases Dictate
CD8+ T-Cell Exclusion in Squamous Cell Carcinoma of the Head and Neck.”Oncotarget 8 (68): 112797–808.
https://doi.org/10.18632/oncotarget.22627.
Wang, Hui, Zhixin Chai, Dan Hu, Qiumei Ji, Jinwei Xin, Chengfu Zhang,
and Jincheng Zhong. 2019. “A Global Analysis of CNVs in Diverse Yak
Populations Using Whole-Genome Resequencing.” BMC Genomics 20
(1): 1–12. https://doi.org/10.1186/s12864-019-5451-5.
Wang, Zhixiang, Yuan Liu, Yong Xue, Haiyan Hu, Jieyu Ye, Xiaodong Li,
Zhigang Lu, Fanyi Meng, and Shuang Liang. 2016. “Berberine Acts as a
Putative Epigenetic Modulator by Affecting the Histone Code.”Toxicology in Vitro 36: 10–17.
https://doi.org/10.1016/j.tiv.2016.06.004.
Wu, Dandan, Yang Chen, Qiming Chen, Guoming Wang, Xiaofeng Xu, A. Peng,
Jin Hao, Jinguang He, Li Huang, and Jiewen Dai. 2019. “Clinical
Presentation and Genetic Profiles of Chinese Patients with
Velocardiofacial Syndrome in a Large Referral Centre.” Journal of
Genetics 98 (2). https://doi.org/10.1007/s12041-019-1090-5.
Xu, Guiliang, Guilin Liu, Sidong Xiong, Haiyan Liu, Xi Chen, and Biao
Zheng. 2015. “The Histone Methyltransferase Smyd2 Is a Negative
Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6)
and Tumor Necrosis Factor α (Tnf-α).” Journal of Biological
Chemistry 290 (9): 5414–23. https://doi.org/10.1074/jbc.M114.610345.
Yahalom, Vered, Nir Pillar, Yingying Zhao, Shirley Modan, Mingyan Fang,
Lydia Yosephi, Orna Asher, et al. 2018. “SMYD1 Is the Underlying Gene
for the AnWj-Negative Blood Group Phenotype.” European Journal of
Haematology 101 (4): 496–501. https://doi.org/10.1111/ejh.13133.
Yamamoto, Keiyu, Takaomi Ishida, Kazumi Nakano, Makoto Yamagishi,
Tadanori Yamochi, Yuetsu Tanaka, Yoichi Furukawa, Yusuke Nakamura, and
Toshiki Watanabe. 2011. “SMYD3 Interacts with HTLV-1 Tax and Regulates
Subcellular Localization of Tax.” Cancer Science 102 (1):
260–66. https://doi.org/10.1111/j.1349-7006.2010.01752.x.
Yi, Xin, Xue Jun Jiang, and Ze Min Fang. 2019. “Histone
Methyltransferase SMYD2: Ubiquitous Regulator of Disease.”Clinical Epigenetics 11 (1): 112.
https://doi.org/10.1186/s13148-019-0711-4.
Yildirim-Buharalioğlu, Gökçe, Mark Bond, Graciela B. Sala-Newby, Charles
C.T. Hindmarch, and Andrew C. Newby. 2017. “Regulation of Epigenetic
Modifiers, Including KDM6B, by Interferon-γ and Interleukin-4 in Human
Macrophages.” Frontiers in Immunology 8 (FEB): 1–18.
https://doi.org/10.3389/fimmu.2017.00092.
Zhang, Ping, Jin Fei Ruan, Wenwen Weng, and Yongmin Tang. 2020.
“Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is
Associated with Poor Prognosis in Pediatric B Lineage Acute
Lymphoblastic Leukemia.” Leukemia and Lymphoma 61 (2): 437–44.
https://doi.org/10.1080/10428194.2019.1675875.
Zhao, Fei, Yan Chen, Linglan Zeng, Rui Li, Rong Zeng, Lu Wen, Yuan Liu,
and Chun Zhang. 2010. “Role of Triptolide in Cell Proliferation, Cell
Cycle Arrest, Apoptosis and Histone Methylation in Multiple Myeloma U266
Cells.” European Journal of Pharmacology 646 (1–3): 1–11.
https://doi.org/10.1016/j.ejphar.2010.05.034.
Zipin-Roitman, Adi, Nasma Aqaqe, Muhammad Yassin, Shahar Biechonski,
Mariam Amar, Mark F. van Delft, Olga I. Gan, et al. 2017. “SMYD2 Lysine
Methyltransferase Regulates Leukemia Cell Growth and Regeneration after
Genotoxic Stress.” Oncotarget 8 (10): 16712–27.
https://doi.org/10.18632/oncotarget.15147.
Zou, Jia Ning, Shu Zhen Wang, Jia Sen Yang, Xue Gang Luo, Jing Hang Xie,
and Tao Xi. 2009. “Knockdown of SMYD3 by RNA Interference
Down-Regulates c-Met Expression and Inhibits Cells Migration and
Invasion Induced by HGF.” Cancer Letters 280 (1): 78–85.
https://doi.org/10.1016/j.canlet.2009.02.015.